$CL

Colgate-Palmolive (NYSE: CL) awards stock to Americas COO

Colgate-Palmolive (CL) granted COO Shane Grant 50,902 stock options at $87.02 per share, expiring in 2036, and 7,355 restricted stock units. This increases his direct holdings to 79,503 shares and 50,902 options. The awards vest over three years, with no Rule 10b5-1 trading plan reported.

Original reporting
Published Sep 18, 2026, 8:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 18, 2026, 9:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$CL
Neutral
high confidence
Mentioned
$CL
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$CLNeutralLow
01

Why it matters

The grant adds to insider holdings but does not change the company's capital structure today.

02

Market read

Routine insider compensation with limited trading relevance.

03

What to watch

Potential future dilution if options are exercised at higher share price.

Relevance 4/10Novelty 3/10Timing: post‑award disclosure Sep 16 2026

Background

Colgate‑Palmolive filed a disclosure of equity awards to its Americas COO.

Company-level read

Ticker impact

$CLNeutralHigh confidence
Context

COO Shane Grant was granted 50,902 stock options and 7,355 RSUs on Sep 16, 2026.

Expected impact

Minimal impact; market likely to view as routine compensation.

Evidence & confidence

The grant is a standard insider compensation event with no cash transaction or dilution effect until exercised.

Market effects

None; compensation grant is company‑specific.

None; limited to Colgate‑Palmolive shareholders.

Low; no broader market effect.

Counterpoint

Even routine grants can signal confidence in future performance.

Key entities

  • Shane Grant

    COO, Americas

Related articles

$CLMed

Piper Sandler cuts Colgate-Palmolive stock price target on cost pressures

Piper Sandler reduced its price target for Colgate-Palmolive (CL) to $95 from $98, citing cost pressures from elevated oil prices and inventory headwinds. The firm maintained an Overweight rating and a 2026 EPS estimate of $3.85, but lowered its 2027 EPS estimate to $4.12 from $4.23. CL trades at $87.47 with a P/E ratio of 34.6 and a gross profit margin of 60%. Other analysts have maintained positive outlooks, with RBC and UBS setting higher price targets.

$CLMedAI 8/10

Colgate-Palmolive Explores Sale Of Softsoap, Irish Spring, Speed Stick Brands: Report

Colgate-Palmolive (CL) is exploring the sale of brands like Softsoap, Irish Spring, and Speed Stick, potentially fetching over $1 billion. The company is working with Goldman Sachs (GS) on the divestiture. Personal care accounted for 17% of CL's 2025 net sales, which totaled $20.38 billion. The move is part of a broader productivity and restructuring program aimed at generating annual pre-tax savings of $200 million to $300 million by 2028.

$CLMedAI 8/10

Colgate-Palmolive reportedly weighs US$1B personal care offload.

Colgate-Palmolive is reportedly considering the sale of select mass-market personal care brands, including Softsoap, Irish Spring, and Speed Stick, for over $1 billion. The company is working with Goldman Sachs on the potential divestment to focus on higher-margin businesses amid North American competition. Personal care accounted for 17% of its 2025 net sales of $20.38 billion.

$CLMed

CL Stock Alert: Colgate-Palmolive Reportedly Considers $1 Billion Brand Sale

Colgate-Palmolive (CL) is reportedly exploring the sale of non-core personal care brands, valued at over $1 billion, with Goldman Sachs' advisory. The move aims to reallocate capital toward higher-growth segments. CL shares are down 12% year-to-date, trading below major moving averages, but offer a 2.44% dividend yield. Institutional investors remain bullish, and the consensus rating is 'Moderate Buy' with a mean price target of $160.

$CLMedAI 8/10

Colgate-Palmolive Seeks Value Through Portfolio Reshaping

Colgate-Palmolive (NYSE:CL) is exploring the sale of mass-market personal care brands, including Softsoap, Irish Spring, and Speed Stick, potentially generating over $1 billion. The move aims to simplify its portfolio and focus on higher-growth areas like oral care and pet nutrition, amid competitive pressure in North America. The company reported a 4.9% increase in net sales, but organic sales in North America declined 3%. Proceeds could be used for debt reduction, share repurchases, or acquisi